Julie Smith sold $4.7M of Exelixis (EXEL)

Executed Feb 17, disclosed Feb 19, 2 days later.

Value, as filed

$4.7M

106,539 sh across 3 lots

Executed

Feb 17

the trade date, as filed

Disclosed

Feb 19

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

JS Julie Smith Director profile →

Julie Smith (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Exelixis, Inc. (EXEL). The largest single filing was $4.7M of EXEL (106,539 sh across 3 lots, as filed), executed Feb 17.

The name

EXEL Exelixis, Inc. EXEL · Healthcare · 53 filings in 24 months ticker →

Healthcare · Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat c…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Julie Smith in EXEL

EXELSALE Exelixis, Inc. $2.8M
73,808 sh across 2 lots
Exec Feb 27 2025
Filed Feb 28 2025 · 5:30 PM ET